Skip to main content
Premium Trial:

Request an Annual Quote

Ordina, Erasmus Medical Center Ally to Provide Genomics, Proteomics Data Analysis

NEW YORK, March 24 (GenomeWeb News) - Ordina, a information-technology service provider based in the Netherlands, yesterday announced a collaboration to develop diagnostics services based on proteomics and gene-expression data with Erasmus Medical Center in Rotterdam.

 

Ordina and the Erasmus Medical Center, which includes the faculty of medicine and health sciences of Erasmus University and the University Hospital of Rotterdam, will initiate projects providing services to analyze the clinical, biological and experimental information from DNA microarray-based experiments.

 

Financial details were not disclosed.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.